Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

The firm said they posted better-than-expected initial data from SPY001 and thinks the data incrementally de-risks its lead asset and broad pipeline, which could offer best-in-class dosing and ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

GET MORE AI-GENERATED SIGNALS: November 13, 2024, 00:14 am ET, BY Simon M.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

Anticipation builds for Indias Best Dancer Season 4 finale with Arjun Kapoor and Tiger Shroff. Expect thrilling performances ...

Bhubaneswar: Smruti Swarup Patra, known by his stage name ‘Nextion’, has emerged as the first runner-up in the ‘Ultimate ...

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...